Plain-English translation of NCT07786649 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two types of non-invasive brain stimulation — transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) — to help stroke survivors recover lost abilities like arm and leg movement, walking, or speech. Researchers want to figure out which patients benefit most from which type of stimulation and how to use these treatments most effectively.
After a stroke, many people have lasting difficulties with movement or speech. Currently, doctors use brain stimulation in different ways, and it's not always clear which approach works best for which patients. This study aims to clarify this by testing specific stimulation protocols tailored to each patient's main goals and medical history.
You likely qualify if…
You likely don't qualify if…
You will start with a baseline assessment to measure your current abilities. Then, over the next month, you will receive either 20 sessions of tDCS or 12 sessions of rTMS — the type and number of sessions will be chosen by the study doctors based on your main recovery goal and medical profile. After your final treatment session and again 6 weeks later, you will complete the same assessments to see how much you have improved.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
Singapore